Photodynamic therapy: one step ahead with self-assembled nanoparticles.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Photochemistry

Background:

• Photodynamic therapy (PDT) utilizes light and photosensitizers (PS) to generate reactive oxygen species (ROS) for cancer treatment.
• Current PS often suffer from poor water solubility, aggregation, and limited tissue penetration, reducing PDT efficacy.
• Nanotechnology offers solutions to improve PS delivery, targeting, and therapeutic outcomes.

Purpose of the Study:

• To review the role of nanotechnology in enhancing photodynamic therapy (PDT).
• To explore non-liposomal self-assembled nanoparticles for improved photosensitizer (PS) delivery.
• To discuss the potential of polymeric micelles, dendrimers, and porphysomes in overcoming PDT limitations.

Main Methods:

• Review of current literature on nanotechnology applications in PDT.
• Focus on self-assembled nanoparticles, including polymeric micelles, dendrimers, and porphysomes.
• Analysis of strategies to improve photosensitizer (PS) solubility, aggregation, and targeted delivery.

Main Results:

• Nanoparticle encapsulation/conjugation enhances cellular uptake and tumor selectivity of PS.
• Self-assembled nanoparticles, particularly non-liposomal ones, mitigate PS aggregation and improve ROS generation.
• Polymeric micelles, dendrimers, and porphysomes show promise as effective nano-drug delivery vehicles for PDT.

Conclusions:

• Nanotechnology significantly improves PDT by addressing photosensitizer (PS) challenges.
• Non-liposomal self-assembled nanoparticles represent a key advancement in PDT drug delivery.
• Further development of nanocarriers holds great potential for enhanced cancer therapy via PDT.